The global Hormone Disorder Drug market was valued at 46.8 million in 2024 and is projected to reach US$ 75.5 million by 2031, at a CAGR of 7.3% during the forecast period.
The hormone disorder drug market is experiencing several key trends driven by factors such as the increasing prevalence of hormone disorders, advancements in medical research, and the growing demand for personalized medicine. Here are some of the trends shaping the hormone disorder drug market:Increasing Prevalence of Hormone Disorders: Hormone disorders, such as hypothyroidism, diabetes, growth hormone deficiency, and hormonal imbalances in women, are becoming more prevalent globally. Factors such as sedentary lifestyles, obesity, aging populations, and environmental factors contribute to the rise in hormone disorders. This increasing prevalence is driving the demand for effective drug treatments to manage and control these conditions.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hormone Disorder Drug manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Hormone Disorder Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormone Disorder Drug. This report contains market size and forecasts of Hormone Disorder Drug in global, including the following market information:
Global Hormone Disorder Drug market revenue, 2020-2025, 2026-2031, ($ millions)
Global Hormone Disorder Drug market sales, 2020-2025, 2026-2031, (K Units)
Global top five Hormone Disorder Drug companies in 2024 (%)
Total Market by Segment:
Global Hormone Disorder Drug market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Hormone Disorder Drug market segment percentages, by Type, 2024 (%)
Growth Hormone Stimulator
Growth Hormone Inhibitor
Global Hormone Disorder Drug market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Hormone Disorder Drug market segment percentages, by Application, 2024 (%)
Dwarfism
Gigantism
Other
Global Hormone Disorder Drug market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Hormone Disorder Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hormone Disorder Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Hormone Disorder Drug revenues share in global market, 2024 (%)
Key companies Hormone Disorder Drug sales in global market, 2020-2025 (estimated), (K Units)
Key companies Hormone Disorder Drug sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries Ltd
Amneal Pharmaceutical Inc
Mayne Pharma Group Limited
Merck KGaA
Sanofi
Sun Pharmaceutical Industries Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Abbott
PT. Daewoong Pharmaceutical Company
Genentech, Inc
Bausch Health Companies Inc
Lilly
Ipsen Pharma
Ferring B.V
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hormone Disorder Drug, market overview.
Chapter 2: Global Hormone Disorder Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Hormone Disorder Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hormone Disorder Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hormone Disorder Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hormone Disorder Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Hormone Disorder Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hormone Disorder Drug Overall Market Size
2.1 Global Hormone Disorder Drug Market Size: 2024 VS 2031
2.2 Global Hormone Disorder Drug Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Hormone Disorder Drug Sales: 2020-2031
3 Company Landscape
3.1 Top Hormone Disorder Drug Players in Global Market
3.2 Top Global Hormone Disorder Drug Companies Ranked by Revenue
3.3 Global Hormone Disorder Drug Revenue by Companies
3.4 Global Hormone Disorder Drug Sales by Companies
3.5 Global Hormone Disorder Drug Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Hormone Disorder Drug Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Hormone Disorder Drug Product Type
3.8 Tier 1, Tier 2, and Tier 3 Hormone Disorder Drug Players in Global Market
3.8.1 List of Global Tier 1 Hormone Disorder Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Hormone Disorder Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Hormone Disorder Drug Market Size Markets, 2024 & 2031
4.1.2 Growth Hormone Stimulator
4.1.3 Growth Hormone Inhibitor
4.2 Segment by Type - Global Hormone Disorder Drug Revenue & Forecasts
4.2.1 Segment by Type - Global Hormone Disorder Drug Revenue, 2020-2025
4.2.2 Segment by Type - Global Hormone Disorder Drug Revenue, 2026-2031
4.2.3 Segment by Type - Global Hormone Disorder Drug Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Hormone Disorder Drug Sales & Forecasts
4.3.1 Segment by Type - Global Hormone Disorder Drug Sales, 2020-2025
4.3.2 Segment by Type - Global Hormone Disorder Drug Sales, 2026-2031
4.3.3 Segment by Type - Global Hormone Disorder Drug Sales Market Share, 2020-2031
4.4 Segment by Type - Global Hormone Disorder Drug Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Hormone Disorder Drug Market Size, 2024 & 2031
5.1.2 Dwarfism
5.1.3 Gigantism
5.1.4 Other
5.2 Segment by Application - Global Hormone Disorder Drug Revenue & Forecasts
5.2.1 Segment by Application - Global Hormone Disorder Drug Revenue, 2020-2025
5.2.2 Segment by Application - Global Hormone Disorder Drug Revenue, 2026-2031
5.2.3 Segment by Application - Global Hormone Disorder Drug Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Hormone Disorder Drug Sales & Forecasts
5.3.1 Segment by Application - Global Hormone Disorder Drug Sales, 2020-2025
5.3.2 Segment by Application - Global Hormone Disorder Drug Sales, 2026-2031
5.3.3 Segment by Application - Global Hormone Disorder Drug Sales Market Share, 2020-2031
5.4 Segment by Application - Global Hormone Disorder Drug Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Hormone Disorder Drug Market Size, 2024 & 2031
6.2 By Region - Global Hormone Disorder Drug Revenue & Forecasts
6.2.1 By Region - Global Hormone Disorder Drug Revenue, 2020-2025
6.2.2 By Region - Global Hormone Disorder Drug Revenue, 2026-2031
6.2.3 By Region - Global Hormone Disorder Drug Revenue Market Share, 2020-2031
6.3 By Region - Global Hormone Disorder Drug Sales & Forecasts
6.3.1 By Region - Global Hormone Disorder Drug Sales, 2020-2025
6.3.2 By Region - Global Hormone Disorder Drug Sales, 2026-2031
6.3.3 By Region - Global Hormone Disorder Drug Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Hormone Disorder Drug Revenue, 2020-2031
6.4.2 By Country - North America Hormone Disorder Drug Sales, 2020-2031
6.4.3 United States Hormone Disorder Drug Market Size, 2020-2031
6.4.4 Canada Hormone Disorder Drug Market Size, 2020-2031
6.4.5 Mexico Hormone Disorder Drug Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Hormone Disorder Drug Revenue, 2020-2031
6.5.2 By Country - Europe Hormone Disorder Drug Sales, 2020-2031
6.5.3 Germany Hormone Disorder Drug Market Size, 2020-2031
6.5.4 France Hormone Disorder Drug Market Size, 2020-2031
6.5.5 U.K. Hormone Disorder Drug Market Size, 2020-2031
6.5.6 Italy Hormone Disorder Drug Market Size, 2020-2031
6.5.7 Russia Hormone Disorder Drug Market Size, 2020-2031
6.5.8 Nordic Countries Hormone Disorder Drug Market Size, 2020-2031
6.5.9 Benelux Hormone Disorder Drug Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Hormone Disorder Drug Revenue, 2020-2031
6.6.2 By Region - Asia Hormone Disorder Drug Sales, 2020-2031
6.6.3 China Hormone Disorder Drug Market Size, 2020-2031
6.6.4 Japan Hormone Disorder Drug Market Size, 2020-2031
6.6.5 South Korea Hormone Disorder Drug Market Size, 2020-2031
6.6.6 Southeast Asia Hormone Disorder Drug Market Size, 2020-2031
6.6.7 India Hormone Disorder Drug Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Hormone Disorder Drug Revenue, 2020-2031
6.7.2 By Country - South America Hormone Disorder Drug Sales, 2020-2031
6.7.3 Brazil Hormone Disorder Drug Market Size, 2020-2031
6.7.4 Argentina Hormone Disorder Drug Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hormone Disorder Drug Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Hormone Disorder Drug Sales, 2020-2031
6.8.3 Turkey Hormone Disorder Drug Market Size, 2020-2031
6.8.4 Israel Hormone Disorder Drug Market Size, 2020-2031
6.8.5 Saudi Arabia Hormone Disorder Drug Market Size, 2020-2031
6.8.6 UAE Hormone Disorder Drug Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Company Summary
7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
7.1.3 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.1.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.2 Amneal Pharmaceutical Inc
7.2.1 Amneal Pharmaceutical Inc Company Summary
7.2.2 Amneal Pharmaceutical Inc Business Overview
7.2.3 Amneal Pharmaceutical Inc Hormone Disorder Drug Major Product Offerings
7.2.4 Amneal Pharmaceutical Inc Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.2.5 Amneal Pharmaceutical Inc Key News & Latest Developments
7.3 Mayne Pharma Group Limited
7.3.1 Mayne Pharma Group Limited Company Summary
7.3.2 Mayne Pharma Group Limited Business Overview
7.3.3 Mayne Pharma Group Limited Hormone Disorder Drug Major Product Offerings
7.3.4 Mayne Pharma Group Limited Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.3.5 Mayne Pharma Group Limited Key News & Latest Developments
7.4 Merck KGaA
7.4.1 Merck KGaA Company Summary
7.4.2 Merck KGaA Business Overview
7.4.3 Merck KGaA Hormone Disorder Drug Major Product Offerings
7.4.4 Merck KGaA Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.4.5 Merck KGaA Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Hormone Disorder Drug Major Product Offerings
7.5.4 Sanofi Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.5.5 Sanofi Key News & Latest Developments
7.6 Sun Pharmaceutical Industries Ltd
7.6.1 Sun Pharmaceutical Industries Ltd Company Summary
7.6.2 Sun Pharmaceutical Industries Ltd Business Overview
7.6.3 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Major Product Offerings
7.6.4 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.6.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Hormone Disorder Drug Major Product Offerings
7.7.4 Novartis AG Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.7.5 Novartis AG Key News & Latest Developments
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Company Summary
7.8.2 F. Hoffmann-La Roche Ltd Business Overview
7.8.3 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.8.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Hormone Disorder Drug Major Product Offerings
7.9.4 Abbott Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.9.5 Abbott Key News & Latest Developments
7.10 PT. Daewoong Pharmaceutical Company
7.10.1 PT. Daewoong Pharmaceutical Company Company Summary
7.10.2 PT. Daewoong Pharmaceutical Company Business Overview
7.10.3 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Major Product Offerings
7.10.4 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.10.5 PT. Daewoong Pharmaceutical Company Key News & Latest Developments
7.11 Genentech, Inc
7.11.1 Genentech, Inc Company Summary
7.11.2 Genentech, Inc Business Overview
7.11.3 Genentech, Inc Hormone Disorder Drug Major Product Offerings
7.11.4 Genentech, Inc Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.11.5 Genentech, Inc Key News & Latest Developments
7.12 Bausch Health Companies Inc
7.12.1 Bausch Health Companies Inc Company Summary
7.12.2 Bausch Health Companies Inc Business Overview
7.12.3 Bausch Health Companies Inc Hormone Disorder Drug Major Product Offerings
7.12.4 Bausch Health Companies Inc Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.12.5 Bausch Health Companies Inc Key News & Latest Developments
7.13 Lilly
7.13.1 Lilly Company Summary
7.13.2 Lilly Business Overview
7.13.3 Lilly Hormone Disorder Drug Major Product Offerings
7.13.4 Lilly Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.13.5 Lilly Key News & Latest Developments
7.14 Ipsen Pharma
7.14.1 Ipsen Pharma Company Summary
7.14.2 Ipsen Pharma Business Overview
7.14.3 Ipsen Pharma Hormone Disorder Drug Major Product Offerings
7.14.4 Ipsen Pharma Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.14.5 Ipsen Pharma Key News & Latest Developments
7.15 Ferring B.V
7.15.1 Ferring B.V Company Summary
7.15.2 Ferring B.V Business Overview
7.15.3 Ferring B.V Hormone Disorder Drug Major Product Offerings
7.15.4 Ferring B.V Hormone Disorder Drug Sales and Revenue in Global (2020-2025)
7.15.5 Ferring B.V Key News & Latest Developments
8 Global Hormone Disorder Drug Production Capacity, Analysis
8.1 Global Hormone Disorder Drug Production Capacity, 2020-2031
8.2 Hormone Disorder Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Hormone Disorder Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hormone Disorder Drug Supply Chain Analysis
10.1 Hormone Disorder Drug Industry Value Chain
10.2 Hormone Disorder Drug Upstream Market
10.3 Hormone Disorder Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hormone Disorder Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Hormone Disorder Drug in Global Market
Table 2. Top Hormone Disorder Drug Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Hormone Disorder Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Hormone Disorder Drug Revenue Share by Companies, 2020-2025
Table 5. Global Hormone Disorder Drug Sales by Companies, (K Units), 2020-2025
Table 6. Global Hormone Disorder Drug Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Hormone Disorder Drug Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Hormone Disorder Drug Product Type
Table 9. List of Global Tier 1 Hormone Disorder Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hormone Disorder Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Hormone Disorder Drug Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Hormone Disorder Drug Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Hormone Disorder Drug Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Hormone Disorder Drug Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Hormone Disorder Drug Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Hormone Disorder Drug Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Hormone Disorder Drug Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Hormone Disorder Drug Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Hormone Disorder Drug Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Hormone Disorder Drug Sales, (K Units), 2026-2031
Table 21. By Region – Global Hormone Disorder Drug Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Hormone Disorder Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Hormone Disorder Drug Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Hormone Disorder Drug Sales, (K Units), 2020-2025
Table 25. By Region - Global Hormone Disorder Drug Sales, (K Units), 2026-2031
Table 26. By Country - North America Hormone Disorder Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Hormone Disorder Drug Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Hormone Disorder Drug Sales, (K Units), 2020-2025
Table 29. By Country - North America Hormone Disorder Drug Sales, (K Units), 2026-2031
Table 30. By Country - Europe Hormone Disorder Drug Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Hormone Disorder Drug Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Hormone Disorder Drug Sales, (K Units), 2020-2025
Table 33. By Country - Europe Hormone Disorder Drug Sales, (K Units), 2026-2031
Table 34. By Region - Asia Hormone Disorder Drug Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Hormone Disorder Drug Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Hormone Disorder Drug Sales, (K Units), 2020-2025
Table 37. By Region - Asia Hormone Disorder Drug Sales, (K Units), 2026-2031
Table 38. By Country - South America Hormone Disorder Drug Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Hormone Disorder Drug Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Hormone Disorder Drug Sales, (K Units), 2020-2025
Table 41. By Country - South America Hormone Disorder Drug Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Hormone Disorder Drug Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Hormone Disorder Drug Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Hormone Disorder Drug Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Hormone Disorder Drug Sales, (K Units), 2026-2031
Table 46. Teva Pharmaceutical Industries Ltd Company Summary
Table 47. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product Offerings
Table 48. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 50. Amneal Pharmaceutical Inc Company Summary
Table 51. Amneal Pharmaceutical Inc Hormone Disorder Drug Product Offerings
Table 52. Amneal Pharmaceutical Inc Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Amneal Pharmaceutical Inc Key News & Latest Developments
Table 54. Mayne Pharma Group Limited Company Summary
Table 55. Mayne Pharma Group Limited Hormone Disorder Drug Product Offerings
Table 56. Mayne Pharma Group Limited Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Mayne Pharma Group Limited Key News & Latest Developments
Table 58. Merck KGaA Company Summary
Table 59. Merck KGaA Hormone Disorder Drug Product Offerings
Table 60. Merck KGaA Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Merck KGaA Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Hormone Disorder Drug Product Offerings
Table 64. Sanofi Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Sanofi Key News & Latest Developments
Table 66. Sun Pharmaceutical Industries Ltd Company Summary
Table 67. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product Offerings
Table 68. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 70. Novartis AG Company Summary
Table 71. Novartis AG Hormone Disorder Drug Product Offerings
Table 72. Novartis AG Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Novartis AG Key News & Latest Developments
Table 74. F. Hoffmann-La Roche Ltd Company Summary
Table 75. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product Offerings
Table 76. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 78. Abbott Company Summary
Table 79. Abbott Hormone Disorder Drug Product Offerings
Table 80. Abbott Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Abbott Key News & Latest Developments
Table 82. PT. Daewoong Pharmaceutical Company Company Summary
Table 83. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product Offerings
Table 84. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. PT. Daewoong Pharmaceutical Company Key News & Latest Developments
Table 86. Genentech, Inc Company Summary
Table 87. Genentech, Inc Hormone Disorder Drug Product Offerings
Table 88. Genentech, Inc Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Genentech, Inc Key News & Latest Developments
Table 90. Bausch Health Companies Inc Company Summary
Table 91. Bausch Health Companies Inc Hormone Disorder Drug Product Offerings
Table 92. Bausch Health Companies Inc Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Bausch Health Companies Inc Key News & Latest Developments
Table 94. Lilly Company Summary
Table 95. Lilly Hormone Disorder Drug Product Offerings
Table 96. Lilly Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Lilly Key News & Latest Developments
Table 98. Ipsen Pharma Company Summary
Table 99. Ipsen Pharma Hormone Disorder Drug Product Offerings
Table 100. Ipsen Pharma Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Ipsen Pharma Key News & Latest Developments
Table 102. Ferring B.V Company Summary
Table 103. Ferring B.V Hormone Disorder Drug Product Offerings
Table 104. Ferring B.V Hormone Disorder Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Ferring B.V Key News & Latest Developments
Table 106. Hormone Disorder Drug Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 107. Global Hormone Disorder Drug Capacity Market Share of Key Manufacturers, 2023-2025
Table 108. Global Hormone Disorder Drug Production by Region, 2020-2025 (K Units)
Table 109. Global Hormone Disorder Drug Production by Region, 2026-2031 (K Units)
Table 110. Hormone Disorder Drug Market Opportunities & Trends in Global Market
Table 111. Hormone Disorder Drug Market Drivers in Global Market
Table 112. Hormone Disorder Drug Market Restraints in Global Market
Table 113. Hormone Disorder Drug Raw Materials
Table 114. Hormone Disorder Drug Raw Materials Suppliers in Global Market
Table 115. Typical Hormone Disorder Drug Downstream
Table 116. Hormone Disorder Drug Downstream Clients in Global Market
Table 117. Hormone Disorder Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hormone Disorder Drug Product Picture
Figure 2. Hormone Disorder Drug Segment by Type in 2024
Figure 3. Hormone Disorder Drug Segment by Application in 2024
Figure 4. Global Hormone Disorder Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Hormone Disorder Drug Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Hormone Disorder Drug Revenue: 2020-2031 (US$, Mn)
Figure 8. Hormone Disorder Drug Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Hormone Disorder Drug Revenue in 2024
Figure 10. Segment by Type – Global Hormone Disorder Drug Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Hormone Disorder Drug Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Hormone Disorder Drug Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Hormone Disorder Drug Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Hormone Disorder Drug Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Hormone Disorder Drug Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Hormone Disorder Drug Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Hormone Disorder Drug Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Hormone Disorder Drug Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Hormone Disorder Drug Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Hormone Disorder Drug Revenue Market Share, 2020-2031
Figure 21. By Region - Global Hormone Disorder Drug Sales Market Share, 2020-2031
Figure 22. By Country - North America Hormone Disorder Drug Revenue Market Share, 2020-2031
Figure 23. By Country - North America Hormone Disorder Drug Sales Market Share, 2020-2031
Figure 24. United States Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Hormone Disorder Drug Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Hormone Disorder Drug Sales Market Share, 2020-2031
Figure 29. Germany Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 30. France Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Hormone Disorder Drug Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Hormone Disorder Drug Sales Market Share, 2020-2031
Figure 38. China Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 42. India Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Hormone Disorder Drug Revenue Market Share, 2020-2031
Figure 44. By Country - South America Hormone Disorder Drug Sales, Market Share, 2020-2031
Figure 45. Brazil Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Hormone Disorder Drug Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Hormone Disorder Drug Sales, Market Share, 2020-2031
Figure 49. Turkey Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Hormone Disorder Drug Revenue, (US$, Mn), 2020-2031
Figure 53. Global Hormone Disorder Drug Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Hormone Disorder Drug by Region, 2024 VS 2031
Figure 55. Hormone Disorder Drug Industry Value Chain
Figure 56. Marketing Channels
